ZBH · Full Picture

ZIMMER BIOMET HOLDINGS, INC. — the full picture

Earnings window · 2026-07-15 to 2026-08-09 · anchored on the 10-Q report

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

1. Gross Margin Drivers · Gross marginPriority 72
   -88.5% operating_income; 4 forward row(s); quote_verified
   Estimated annual amortization expense based on intangibles as of December 31, 2025: 2026 $633.6 million, 2027 $619.8 million, 2028 $613.6 million, 2029 $564.9 million, 2030 $448.4 million.
2. Inventory Levels and Obsolescence · Supply chain & operationsPriority 71
   -15.2% operating_income (realized); quote_verified
   Inventory and instrument charges of approximately $170 million were recorded related to certain product lines the company intends to discontinue.
3. Capital Return Program · Buybacks & dividendsPriority 68
   1 forward row(s); quote_verified
   Company announced increase to share repurchase expectations of up to $1 billion of its common stock during fiscal year 2026
4. Headcount / Restructuring · Restructuring & impairmentPriority 66
   -2.7% operating_income; 2 sources (news, press_release); 3 forward row(s); quote_verified
   Zimmer Biomet's 2025 Restructuring Plan was approved in February 2025 and expanded in December 2025 and is expected to result in total pre-tax restructuring charges of approximately $155 million by the end of 2027.
5. Share-Based Compensation · UnclassifiedPriority 61
   -3.9% operating_income; 1 forward row(s); quote_verified
   As of December 31, 2025 Zimmer Biomet estimates 1,944,684 outstanding RSUs will vest; unrecognized share-based payment expense was $100.7 million expected to be recognized over a weighted-average period of 1.8 years.
6. Outstanding Indebtedness · Debt, leverage & refinancingPriority 59
   -5.1% liability (realized); quote_verified
   In 2025 the company issued senior notes for proceeds of $2,492.1 million, redeemed $1,463.0 million of senior notes, and repurchased $487.0 million of common stock.
7. Geographic Market Commentary · Geographic mixPriority 58
   +10.5% revenue (realized); quote_verified
   Balance of total goodwill by segment at December 31, 2025: Americas goodwill $9,256.4 million, EMEA $1,405.4 million, Asia Pacific $619.8 million; total goodwill $11,281.6 million.
8. Contingent Consideration Liability · UnclassifiedPriority 57
   +3.5% net_income (realized); 1 forward row(s); quote_verified
   For acquisitions with contingent consideration, the range of potential contingent consideration payments is $25 million to $795 million as of December 31, 2025, payable through 2031.
9. Capital Expenditures · Capital expenditurePriority 56
   1 forward row(s); quote_verified
   Future minimum lease payments as of December 31, 2025: 2026 $64.2 million; 2027 $52.8 million; 2028 $37.5 million; 2029 $28.4 million; 2030 $21.0 million; Thereafter $59.1 million; Total $263.0 million; Less imputed interest $30.0 million; Total present value $233.0 million.
10. Guidance / Outlook · Guidance & outlookPriority 56
    +1.4% revenue; 2 sources (news, press_release); 6 forward row(s); quote_verified
    2026 outlook expects year-over-year net sales growth of 2.5 percent to 4.5 percent.
11. Acquisitions and Partnerships · M&A and divestituresPriority 53
    -0.0% liability; 5 forward row(s); quote_verified
    The Monogram CVRs may result in up to approximately $570 million in additional consideration if milestones are achieved through 2030.
12. Inventory Cost Pressure · Supply chain & operationsPriority 53
    qualitative only

Threads by pillar

Revenue & Demand Priority 75 · 9 threads

• Geographic Market CommentaryPriority 58 · Release
• Geographic Revenue ConcentrationPriority 51 · Release
• Product Category Demand TrendsPriority 53 · News, Release
• Distribution ChannelsPriority 48 · Release
• IRS Transfer Pricing DisputePriority 44 · Release
• Product Launch and TransitionPriority 35 · Release
• Products and TechnologyPriority 32 · News
• Revenue Performance and MixPriority 35 · News, Release
• Segment Revenue RecastPriority 25 · Release

Costs & Margins Priority 83 · 7 threads

• Inventory Levels and ObsolescencePriority 71 · Release
• Inventory Cost PressurePriority 53 · Release
• Supply Chain and ERP ExecutionPriority 21 · Release
• Gross Margin DriversPriority 72 · Release
• Headcount / RestructuringPriority 66 · News, Release
• Net Income and EPS PerformancePriority 47 · News, Release
• Operating Expense TrendsPriority 38 · Release

Capital & Balance Sheet Priority 79 · 6 threads

• Capital Return ProgramPriority 68 · Release
• Quarterly Dividend DeclarationPriority 32 · News
• Outstanding IndebtednessPriority 59 · Release
• Capital ExpendituresPriority 56 · Release
• Operating Cash Flow TrendsPriority 50 · Release
• Income Tax Rate ChangesPriority 45 · Release

Strategy & Portfolio Priority 55 · 2 threads

• Acquisitions and PartnershipsPriority 53 · Release
• Sales Force TransformationPriority 32 · News

Legal, Regulatory & Policy Priority 61 · 5 threads

• Regulatory Approval MilestonesPriority 51 · Release
• Regulatory RiskPriority 50 · Release
• Litigation and Legal RiskPriority 50 · Release
• China Distributor LitigationPriority 28 · Release
• Trade Policy and TariffsPriority 21 · Release

Guidance & Outlook Priority 56 · 1 thread

• Guidance / OutlookPriority 56 · News, Release

Macro & Market Conditions Priority 47 · 5 threads

• FX / Currency HeadwindsPriority 39 · Release
• Interest Rate and Refinancing ExposurePriority 32 · Release
• Competition and Market SharePriority 24 · News
• Competition and Pricing PressurePriority 20 · Release
• Macroeconomic Factors ImpactPriority 18 · Release

Unclassified Priority 72 · 5 threads

• Share-Based CompensationPriority 61 · Release
• Contingent Consideration LiabilityPriority 57 · Release
• Liquidity and Debt PositionPriority 52 · Release
• Operating Margin DriversPriority 41 · Release
• OECD Global Minimum TaxPriority 34 · Release

Expected impact by metric